We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Efficacy of the novel antidepressant agomelatine for anxiety symptoms in major depression.
- Authors
Stein, Dan J; Picarel-Blanchot, Francoise; Kennedy, Sidney H
- Abstract
Anxiety in major depression is associated with increased morbidity. The antidepressant, agomelatine, which acts as an agonist at melatonin MT(1) and MT(2) receptors and as an antagonist at serotonin 5-HT(2C) receptors, has demonstrated efficacy and safety in both major depression and generalized anxiety disorder. Here, we investigated the efficacy of agomelatine in anxious depression.
- Publication
Human psychopharmacology, 2013, Vol 28, Issue 2, p151
- ISSN
1099-1077
- Publication type
Journal Article
- DOI
10.1002/hup.2294